These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 20346872)
1. 18F-FDG PET/CT-related metabolic parameters and their value in early prediction of chemotherapy response in a VX2 tumor model. Song SL; Deng C; Wen LF; Liu JJ; Wang H; Feng D; Wong CY; Huang G Nucl Med Biol; 2010 Apr; 37(3):327-33. PubMed ID: 20346872 [TBL] [Abstract][Full Text] [Related]
2. Shortened acquisition protocols for the quantitative assessment of the 2-tissue-compartment model using dynamic PET/CT 18F-FDG studies. Strauss LG; Pan L; Cheng C; Haberkorn U; Dimitrakopoulou-Strauss A J Nucl Med; 2011 Mar; 52(3):379-85. PubMed ID: 21321263 [TBL] [Abstract][Full Text] [Related]
3. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer. Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572 [TBL] [Abstract][Full Text] [Related]
4. Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI. Cheon GJ; Kim MS; Lee JA; Lee SY; Cho WH; Song WS; Koh JS; Yoo JY; Oh DH; Shin DS; Jeon DG J Nucl Med; 2009 Sep; 50(9):1435-40. PubMed ID: 19690035 [TBL] [Abstract][Full Text] [Related]
5. Changes in 18F-FDG uptake within minutes after chemotherapy in a rabbit VX2 tumor model. Song SL; Liu JJ; Huang G; Wang ZH; Song YY; Sun XG; Chen T J Nucl Med; 2008 Feb; 49(2):303-9. PubMed ID: 18199614 [TBL] [Abstract][Full Text] [Related]
6. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Collins DA; Kasperbauer JL; Strome SE; Reading CC; Hay ID; Lowe VJ Nucl Med Commun; 2007 May; 28(5):373-81. PubMed ID: 17414887 [TBL] [Abstract][Full Text] [Related]
7. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin. Zhang M; Jiang X; Zhang M; Xu H; Zhai G; Li B J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438 [TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of gross tumor size using CT, 18F-FDG PET, integrated 18F-FDG PET/CT and pathological analysis in non-small cell lung cancer. Yu HM; Liu YF; Hou M; Liu J; Li XN; Yu JM Eur J Radiol; 2009 Oct; 72(1):104-13. PubMed ID: 18640802 [TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer. Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965 [TBL] [Abstract][Full Text] [Related]
11. [Which is the best monitoring study (tumor marker, computed tomography or 18F-fluoro-2-deoxy-D-glucose positron emission tomography) to evaluate efficacy of chemotherapy on unresectable pancreatic cancer ?]. Kobayashi N; Fujita K; Fujisawa T; Takahashi H; Yoneda M; Abe Y; Inamori M; Kirikoshi H; Kubota K; Saito S; Nakajima A Gan To Kagaku Ryoho; 2008 Jan; 35(1):65-70. PubMed ID: 18195530 [TBL] [Abstract][Full Text] [Related]
12. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study. Iagaru A; Mittra E; Yaghoubi SS; Dick DW; Quon A; Goris ML; Gambhir SS J Nucl Med; 2009 Apr; 50(4):501-5. PubMed ID: 19289439 [TBL] [Abstract][Full Text] [Related]
13. Simplifications in analyzing positron emission tomography data: effects on outcome measures. Logan J; Alexoff D; Kriplani A Nucl Med Biol; 2007 Oct; 34(7):743-56. PubMed ID: 17921027 [TBL] [Abstract][Full Text] [Related]
14. Uncertainty and sensitivity analysis of biokinetic models for radiopharmaceuticals used in nuclear medicine. Li WB; Hoeschen C Radiat Prot Dosimetry; 2010; 139(1-3):228-31. PubMed ID: 20185457 [TBL] [Abstract][Full Text] [Related]
15. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer. Spratt DE; Diaz R; McElmurray J; Csiki I; Duggan D; Lu B; Delbeke D Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of tumor FDG transport and metabolism in primary central nervous system lymphoma using [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) kinetic analysis. Kawai N; Nishiyama Y; Miyake K; Tamiya T; Nagao S Ann Nucl Med; 2005 Dec; 19(8):685-90. PubMed ID: 16444994 [TBL] [Abstract][Full Text] [Related]
17. Kinetic analysis of experimental rabbit tumour and inflammation model with 18F-FDG PET/CT. Liu P; Huang G; Dong S; Wan L Nuklearmedizin; 2009; 48(4):153-8. PubMed ID: 19384450 [TBL] [Abstract][Full Text] [Related]